ResearcherChinese Academy of SciencesActive in the last 2 years
Jun-Li Yang
Matched on ORCID iD 0000-0001-7199-0214; OpenAlex author ID A5028720143, A5123760433. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 7)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 7
- Design, synthesis and biological evaluation of novel ursolic acid derivatives as potent anti-pancreatic cancer agents. Last author DOI 10.1016/j.bmc.2026.118607↗
- Design, synthesis, and biological evaluation of bergapten derivatives as potent anti-pancreatic cancer agents. Last author DOI 10.1080/10286020.2025.2514692↗
- Obacunone potentiated PD-1 immunotherapy in pancreatic cancer by mediating CD36. Last author DOI 10.1016/j.ejphar.2025.177367↗
- Pin1: Advances in pancreatic cancer therapeutic potential and inhibitors research. Last author DOI 10.1016/j.bioorg.2024.107869↗
- Sesquiterpene coumarins from Ferula sinkiangensis and their anti-pancreatic cancer effects. Last author DOI 10.1016/j.phytochem.2023.113824↗
- Terpenoids from Nardostachys jatamansi and their cytotoxic activity against human pancreatic cancer cell lines. Last author DOI 10.1016/j.phytochem.2022.113228↗
- A Carabrane-Type Sesquiterpenolide Carabrone from Carpesium cernuum Inhibits SW1990 Pancreatic Cancer Cells by Inducing Ferroptosis. Last author DOI 10.3390/molecules27185841↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yi-Dan Zheng · 5 shared papers, 2022–2026 · strength 1.12
- Paper Pin1: Advances in pancreatic cancer therapeutic potential and inhibitors research. DOI 10.1016/j.bioorg.2024.107869↗
- Paper Obacunone potentiated PD-1 immunotherapy in pancreatic cancer by mediating CD36. DOI 10.1016/j.ejphar.2025.177367↗
- Paper Design, synthesis and biological evaluation of novel ursolic acid derivatives as potent anti-pancreatic cancer agents. DOI 10.1016/j.bmc.2026.118607↗
- Chun-Yan Sang · 5 shared papers, 2022–2025 · strength 1.07
- Paper Pin1: Advances in pancreatic cancer therapeutic potential and inhibitors research. DOI 10.1016/j.bioorg.2024.107869↗
- Paper Obacunone potentiated PD-1 immunotherapy in pancreatic cancer by mediating CD36. DOI 10.1016/j.ejphar.2025.177367↗
- Paper A Carabrane-Type Sesquiterpenolide Carabrone from Carpesium cernuum Inhibits SW1990 Pancreatic Cancer Cells by Inducing… DOI 10.3390/molecules27185841↗
- Nan Wang · 2 shared papers, 2024–2026 · strength 0.51
- Ying Yue · 1 shared paper, 2026 · strength 0.36
- Tharcisse Gatera · 1 shared paper, 2026 · strength 0.25
- Jialin Wang · 1 shared paper, 2023 · strength 0.19
- Li-Mei Ma · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.